SK281626B6 - Transdermálny terapeutický systém s obsahom estradiolu - Google Patents

Transdermálny terapeutický systém s obsahom estradiolu Download PDF

Info

Publication number
SK281626B6
SK281626B6 SK220-97A SK22097A SK281626B6 SK 281626 B6 SK281626 B6 SK 281626B6 SK 22097 A SK22097 A SK 22097A SK 281626 B6 SK281626 B6 SK 281626B6
Authority
SK
Slovakia
Prior art keywords
estradiol
matrix
transdermal therapeutic
therapeutic system
active substance
Prior art date
Application number
SK220-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK22097A3 (en
Inventor
Walter Mller
Michael Horstmann
Original Assignee
Lts Lohmann Therapie-Systeme Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Gmbh filed Critical Lts Lohmann Therapie-Systeme Gmbh
Publication of SK22097A3 publication Critical patent/SK22097A3/sk
Publication of SK281626B6 publication Critical patent/SK281626B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
SK220-97A 1994-08-20 1995-08-12 Transdermálny terapeutický systém s obsahom estradiolu SK281626B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4429667A DE4429667C2 (de) 1994-08-20 1994-08-20 Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
PCT/EP1995/003201 WO1996005814A1 (de) 1994-08-20 1995-08-12 Estradiol-tts mit wasserbindenden zusätzen

Publications (2)

Publication Number Publication Date
SK22097A3 SK22097A3 (en) 1997-07-09
SK281626B6 true SK281626B6 (sk) 2001-05-10

Family

ID=6526231

Family Applications (1)

Application Number Title Priority Date Filing Date
SK220-97A SK281626B6 (sk) 1994-08-20 1995-08-12 Transdermálny terapeutický systém s obsahom estradiolu

Country Status (22)

Country Link
US (1) US5902602A (hu)
EP (1) EP0776199B1 (hu)
JP (1) JP3825799B2 (hu)
KR (1) KR100401136B1 (hu)
CN (1) CN1078461C (hu)
AT (1) ATE185067T1 (hu)
AU (1) AU695970B2 (hu)
CZ (1) CZ289397B6 (hu)
DE (2) DE4429667C2 (hu)
DK (1) DK0776199T3 (hu)
ES (1) ES2139932T3 (hu)
FI (1) FI118720B (hu)
GR (1) GR3032218T3 (hu)
HU (1) HU226959B1 (hu)
IL (1) IL114949A (hu)
MX (1) MX9701302A (hu)
NO (1) NO313984B1 (hu)
NZ (1) NZ291813A (hu)
PL (1) PL180965B1 (hu)
SK (1) SK281626B6 (hu)
WO (1) WO1996005814A1 (hu)
ZA (1) ZA956925B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
DE19713141A1 (de) * 1996-03-29 1997-10-30 Labtec Gmbh Transdermales System mit Melatonin
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
US10493049B2 (en) 2016-02-10 2019-12-03 Niracle LLC Applicator-based transdermal drug delivery system for administration of drugs in combination with topical formulations
EP4308088A1 (en) 2021-11-08 2024-01-24 Weiyong Li Transdermal drug delivery system for delivering a drug to a patient

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12731T1 (de) * 1979-01-11 1985-05-15 Key Pharma Polymere diffusionsmatrix und verfahren zu deren herstellung.
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
CA1163559A (en) * 1980-07-09 1984-03-13 Alec D. Keith Polymeric diffusion matrix for administration of drugs
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
ZA853488B (en) * 1984-05-10 1986-12-30 American Home Prod Transdermal dosage form
US4810499A (en) * 1984-10-01 1989-03-07 Biotek, Inc. Transdermal drug delivery system and method
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
US4764379A (en) * 1987-08-24 1988-08-16 Alza Corporation Transdermal drug delivery device with dual permeation enhancers
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
DD279818A1 (de) * 1989-02-06 1990-06-20 Jenapharm Veb Verfahren zur herstellung eines medizinischen pflasters
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
AR246186A1 (es) * 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
JPH08501529A (ja) * 1992-06-11 1996-02-20 セラテック・インコーポレイテッド 皮膚透過薬剤投与緩和のグリセリン使用
CA2161004C (en) * 1993-04-20 2004-10-26 Wilfried Fischer Active ingredient patch

Also Published As

Publication number Publication date
DE59506962D1 (de) 1999-11-04
AU695970B2 (en) 1998-08-27
KR970705381A (ko) 1997-10-09
JP3825799B2 (ja) 2006-09-27
SK22097A3 (en) 1997-07-09
AU3344995A (en) 1996-03-14
HUT77085A (hu) 1998-03-02
WO1996005814A1 (de) 1996-02-29
NO970360L (no) 1997-01-28
DK0776199T3 (da) 2000-04-10
GR3032218T3 (en) 2000-04-27
EP0776199B1 (de) 1999-09-29
CN1155835A (zh) 1997-07-30
FI970701A (fi) 1997-02-19
CN1078461C (zh) 2002-01-30
DE4429667A1 (de) 1996-02-22
CZ50997A3 (en) 1997-06-11
MX9701302A (es) 1998-05-31
NO970360D0 (no) 1997-01-28
CZ289397B6 (cs) 2002-01-16
FI970701A0 (fi) 1997-02-19
PL319013A1 (en) 1997-07-21
FI118720B (fi) 2008-02-29
EP0776199A1 (de) 1997-06-04
PL180965B1 (pl) 2001-05-31
JPH10504313A (ja) 1998-04-28
ES2139932T3 (es) 2000-02-16
IL114949A (en) 1998-12-27
KR100401136B1 (ko) 2004-03-31
DE4429667C2 (de) 1996-07-11
NZ291813A (en) 1998-01-26
ATE185067T1 (de) 1999-10-15
IL114949A0 (en) 1995-12-08
NO313984B1 (no) 2003-01-13
US5902602A (en) 1999-05-11
ZA956925B (en) 1996-03-25
HU226959B1 (en) 2010-03-29

Similar Documents

Publication Publication Date Title
FI103478B (fi) Menetelmä transdermaalisen terapeuttisen järjestelmän valmistamiseksi, jossa vaikuttavan aineen virtausta on suurennettu
RU2140784C1 (ru) Содержащая эстрадиол трансдермальная терапевтическая система
US5830505A (en) Active ingredient patch
EP1121941B1 (en) Sorbefacients and preparations for percutaneous absorption containing the same
IE912181A1 (en) Patch with a high content of softening ingredients
SK279112B6 (sk) Spôsob výroby transdermálneho terapeutického systé
US20060088580A1 (en) Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion
EP1827398A2 (de) Transdermales therapeutisches system mit aktivierbarer übersättigung und kontrollierter permeationsförderung
SK32795A3 (en) Dexpanthenol containing plaster for the transdermal application of steroid hormones
CA2443128A1 (en) Transdermal delivery of pergolide
SK280081B6 (sk) Transdermálny terapeutický systém a spôsob jeho vý
CZ75797A3 (en) Transdermal therapeutic system having the form of an adhesive plaster
SK281626B6 (sk) Transdermálny terapeutický systém s obsahom estradiolu
SK3052000A3 (en) Transdermal therapeutic system containing the active substance scopolamine base
MX2007007418A (es) Emplasto transdermico con ligandos especificos de progesterona a (prasl) como principio activo.
EP2371360B1 (en) Selegiline-containing adhesive preparation
SK67498A3 (en) Surface-stabilised pharmaceutical preparation for application on the skin
PL187275B1 (pl) Preparat farmaceutyczny, zwłaszcza transdermalny system terapeutyczny, zawierający 17-beta-estradiol oraz sposób wytwarzania tego preparatu farmaceutycznego
SK21997A3 (en) Transdermal therapeutic system and a method for producing same
JP2003505411A (ja) カルシウムアンタゴニストを投与するための経皮治療系
CA2410336A1 (en) Transdermal therapeutical system with a reduced tendency of the active substance to crystallize
CA2197867C (en) Oestradiol transdermal therapeutic system comprising hygroscopic additives
CZ2000716A3 (cs) Transdermální terapeutický systém s basí skopolaminu jako účinnou látkou

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20120812